C3 Glomerulonephritis: Clinical Trials

1 trial for C3 Glomerulonephritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow C3 Glomerulonephritis: new trials by email Literature Review of C3 Glomerulonephritis trials Research Report on C3 Glomerulonephritis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
CDX-1135 - Dense Deposit Disease, Membranoproliferative Glomerulonephritis Type II
Phase 1TerminatedCelldex Therapeutics12013-01-012014-03-07

Narrower conditions

Glomerulonephritis, Membranoproliferative (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Immune System Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Sponsors

Celldex Therapeutics (1)

Countries

United States (1)

Top investigators

Carla Nester, MD, MSA (1)  ·  Richard Smith, MD (1)